top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae's Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months. By engaging with a broader community, Invitae, a leader in the rare pediatric neurodevelopmental field, aims to create value for significantly more patients with rare diseases.

Recent Posts

Wavemaker 360 News

Carlsmed.png

Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health ...

MedTech Money

Portfolio Company

Carlsmed.png

Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pu ...

Cision PR Newsire

Portfolio Company

Carlsmed.png

Caduceus Capital Partners, Wavemaker Three-Sixty Health Co-Lead Series A Investm ...

Businesswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page